European association of urology guidelines on the diagnosis and management of female non-neurogenic lower urinary tract symptoms. Part 1: diagnostics, overactive …

AK Nambiar, S Arlandis, K Bø, H Cobussen-Boekhorst… - European urology, 2022 - Elsevier
Context Female lower urinary tract symptoms (LUTS) are a common presentation in
urological practice. Thus far, only a limited number of female LUTS conditions have been …

Menopausal hormone therapy and women's health: An umbrella review

GQ Zhang, JL Chen, Y Luo, MB Mathur… - PLoS …, 2021 - journals.plos.org
Background There remains uncertainty about the impact of menopausal hormone therapy
(MHT) on women's health. A systematic, comprehensive assessment of the effects on …

The 2022 hormone therapy position statement of the North American Menopause Society

SS Faubion, CJ Crandall, L Davis… - …, 2022 - ingentaconnect.com
“The 2022 Hormone Therapy Position Statement of The North American Menopause
Society”(NAMS) updates “The 2017 Hormone Therapy Position Statement of The North …

Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment 2019

DJ Lightner, A Gomelsky, L Souter… - The Journal of …, 2019 - auajournals.org
Purpose: The purpose of this guideline is to provide a clinical framework for the diagnosis
and treatment of non-neurogenic overactive bladder (OAB). Materials & Methods: The …

Urinary incontinence in women

Y Aoki, HW Brown, L Brubaker, JN Cornu… - Nature reviews Disease …, 2017 - nature.com
Urinary incontinence symptoms are highly prevalent among women, have a substantial
effect on health-related quality of life and are associated with considerable personal and …

Urinary incontinence in women: a review

ES Lukacz, Y Santiago-Lastra, ME Albo, L Brubaker - Jama, 2017 - jamanetwork.com
Importance Urinary incontinence, the involuntary loss of urine, is a common health condition
that may decrease quality of life. Ten to twenty percent of women and up to 77% of women …

2016 IMS Recommendations on women's midlife health and menopause hormone therapy

RJ Baber, N Panay, A Fenton - Climacteric, 2016 - Taylor & Francis
Abstract The International Menopause Society (IMS) has produced these new 2016
recommendations on women's midlife health and menopause hormone therapy (MHT) to …

Management of menopause: a view towards prevention

RA Lobo, A Gompel - The Lancet Diabetes & Endocrinology, 2022 - thelancet.com
Women spend approximately one-third of their lives with menopause, which occurs around
50 years of age. It is now appreciated that several important metabolic and cardiovascular …

A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment

B Peyronnet, E Mironska, C Chapple, L Cardozo… - European urology, 2019 - Elsevier
Context Current literature suggests that several pathophysiological factors and mechanisms
might be responsible for the nonspecific symptom complex of overactive bladder (OAB) …

Treatment of symptoms of the menopause: an endocrine society clinical practice guideline

CA Stuenkel, SR Davis, A Gompel… - The Journal of …, 2015 - academic.oup.com
Objective: The objective of this document is to generate a practice guideline for the
management and treatment of symptoms of the menopause. Participants: The Treatment of …